BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 14602773)

  • 1. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
    Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.
    Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of expression and physiological effects of sst1 and sst2 receptor subtypes in mouse hypothalamic neurons and astrocytes in culture.
    Viollet C; Lanneau C; Faivre-Bauman A; Zhang J; Djordjijevic D; Loudes C; Gardette R; Kordon C; Epelbaum J
    J Neurochem; 1997 Jun; 68(6):2273-80. PubMed ID: 9166719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
    Schaer JC; Waser B; Mengod G; Reubi JC
    Int J Cancer; 1997 Mar; 70(5):530-7. PubMed ID: 9052751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
    Spary EJ; Maqbool A; Batten TF
    J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures.
    Vasilaki A; Papadaki T; Notas G; Kolios G; Mastrodimou N; Hoyer D; Tsilimbaris M; Kouroumalis E; Pallikaris I; Thermos K
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1499-506. PubMed ID: 15111608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain.
    Videau C; Hochgeschwender U; Kreienkamp HJ; Brennan MB; Viollet C; Richter D; Epelbaum J
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):562-71. PubMed ID: 12759718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding properties of somatostatin receptor subtypes.
    Bruns C; Raulf F; Hoyer D; Schloos J; Lübbert H; Weckbecker G
    Metabolism; 1996 Aug; 45(8 Suppl 1):17-20. PubMed ID: 8769372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
    Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
    J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of multiple somatostatin receptors in the rat cerebellum during development.
    Viollet C; Bodenant C; Prunotto C; Roosterman D; Schaefer J; Meyerhof W; Epelbaum J; Vaudry H; Leroux P
    J Neurochem; 1997 Jun; 68(6):2263-72. PubMed ID: 9166718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin sst2 receptor knock-out mice: localisation of sst1-5 receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography.
    Hannon JP; Petrucci C; Fehlmann D; Viollet C; Epelbaum J; Hoyer D
    Neuropharmacology; 2002 Mar; 42(3):396-413. PubMed ID: 11897118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries.
    Kimura N; Tomizawa S; Arai KN; Kimura N
    Endocrinology; 1998 Apr; 139(4):1573-80. PubMed ID: 9528936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: an electrophysiological and single cell RT-PCR study.
    Lanneau C; Viollet C; Faivre-Bauman A; Loudes C; Kordon C; Epelbaum J; Gardette R
    Eur J Neurosci; 1998 Jan; 10(1):204-12. PubMed ID: 9753128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro.
    Zatelli MC; Piccin D; Tagliati F; Bottoni A; Ambrosio MR; Margutti A; Scanarini M; Bondanelli M; Culler MD; degli Uberti EC
    J Mol Endocrinol; 2005 Oct; 35(2):333-41. PubMed ID: 16216913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
    Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
    Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.